The Problem: The Unmet Need in Radiation Care
Radiation dermatitis is one of the most common and distressing side effects of cancer treatment. Despite its prevalence, there are no approved, effective topical therapies designed specifically for this condition.
- Affects up to 95% of patients undergoing radiation therapy.
- Current options (e.g., corticosteroids, silver sulfadiazine) provide limited relief.
- No Rx-strength topical treatment currently exists.
Our Solution: A Novel CBD-Based Topical Cream
Our formulation leverages the therapeutic potential of Cannabidiol (CBD) through a patented nano-delivery system engineered for enhanced skin penetration and efficacy.
- Targets CB2 receptors, reducing inflammation and tissue damage.
- Uses nano-structured lipid carriers (NLCs) for efficient delivery.
- Encapsulation improves solubility and absorption through the stratum corneum.
- Based on a patented platform for controlled and sustained release.
Validation: Science Backed Results
Our approach is supported by both preclinical and in-vivo data demonstrating efficacy in reducing skin damage and inflammation associated with radiation exposure.
Key Findings:
- Demonstrated reduction in oxidative stress and accelerated wound healing.
- CBD shown to reduce inflammation and pain in topical applications.
- In-vivo studies: Blinded clinical dermatitis scoring (≥2) and reduction in the percentage of animals with severe skin damage (redness score ≥3).
Benefits: Efficacy, Comfort, and Innovation
Our breakthrough topical treatment brings comfort and accelerated healing where current therapies fall short.
- Reduces burning, itching, and pain associated with radiation dermatitis.
- Uses a patented water-based micellar system, increasing CBD efficacy by up to 5x compared to similar products.
- Is the first Rx-strength topical CBD cream designed specifically for radiation dermatitis.